Nabriva Announces Availability of XENLETA® (lefamulin) in a 10-Count Oral Pack by Carolyn Helms | Nov 11, 2021 | Portfolio News
Checkmate Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Business Update by Carolyn Helms | Nov 11, 2021 | Portfolio News
89bio Reports Third Quarter 2021 Financial Results and Provides Corporate Update by Carolyn Helms | Nov 11, 2021 | Portfolio News
Generate Life Sciences to be acquired by CooperCompanies by Carolyn Helms | Nov 10, 2021 | Portfolio News
CooperCompanies to Acquire Generate Life Sciences® for $1.6 Billion by Carolyn Helms | Nov 10, 2021 | Portfolio News
